Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
95
NCT02950064
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2016
Completion: Aug 31, 2020